Reformulation means the product you bought now may not be the product tested or used before. But two common shortcuts are both unreliable: “the list changed, so the new formula is worse,” and “the list looks the same, so nothing changed.” Ingredient lists reveal declared identity and approximate order; they do not reveal exact percentages, pH, processing, stability, or how a formula feels. FDA says retail cosmetic ingredients are generally listed by common or usual name in descending order of predominance (FDA ingredient names).

The practical verdict is a comparison record, not a nostalgia-based ranking.

What a label can show

Save a photo of the entire label and record the market, lot or batch code, net contents, and the date you saw it. Then compare the old and new lists character by character. A new ingredient, a removed ingredient, a changed active panel, or a different warning is a real clue that the declared product changed.

In the U.S., the ingredient list belongs on a retail cosmetic’s information panel and generally uses common or usual names in descending order (FDA ingredient names). That is useful label literacy, not a public formula dossier. FDA also says cosmetics generally do not require premarket approval and that companies are responsible for safety and truthful labeling (FDA authority).

In the EU, the responsible person must keep a product information file and an up-to-date safety report. The label lists ingredients in descending order above 1%; ingredients below 1% may appear in any order. The regulation also requires claims not to imply characteristics the product does not have (Regulation 1223/2009, Articles 10, 11, 19 and 20). This is why a rearranged tail of an EU list is not automatically proof of a new formula.

What the label cannot show

The list does not give you exact concentration, pH, particle size, purity, preservative performance, manufacturing temperature, stability, package interaction, or a sensory test. A changed order can reflect a threshold rule or labeling update; a stable list can hide a change in grade, supplier, processing, or amount that does not alter the declared order. Those are unknowns unless the brand publishes controlled details (FDA ingredient names; EU Regulation 1223/2009).

Do not infer that the new version is safer, harsher, more effective, or less effective from one ingredient moving down the list. FDA’s framework requires truthful labeling but does not require a public reformulation timeline or a consumer-facing report of every process change (FDA cosmetics labeling).

The sunscreen exception that clarifies the rule

Sunscreen makes the market/formula problem easier to see. In the United States, sunscreen is regulated as an OTC drug, with an active-ingredient panel and finished-product SPF and broad-spectrum testing requirements. FDA explicitly warns that some countries regulate sunscreens as cosmetics and tells consumers to read imported labels for differences (FDA sunscreen guidance; OTC Monograph M020).

That does not mean every moisturizer changes between countries. It does mean a study or label from one market cannot automatically answer for another market, especially when the regulatory category or permitted actives differ (FDA sunscreen guidance).

A calm comparison protocol

  1. Photograph both full packages and write down the market, batch, date, net contents, and seller.
  2. Compare the complete INCI and, where relevant, the active-ingredient panel and warnings.
  3. Ask the brand for the reformulation date, reason, and the exact versions being compared. Treat a generic “same great formula” answer as unresolved, not proof.
  4. If your skin reacts, stop the suspect product and simplify the routine while seeking clinical advice for persistent or severe symptoms. A reaction does not prove which ingredient changed.

One useful detail is that a rearranged tail of an EU ingredient list is not automatically evidence of a formula change: ingredients below 1% may be listed in any order. No source here establishes a universal time lag between a formula change and an ingredient-list update, so that timing remains unknown (EU Regulation 1223/2009).

Evidence is mixed: the labeling rules are clear, but finished-product reformulation histories and performance comparisons are usually private and product-specific.

Sources

This answer explains label comparison. It is not medical or legal advice.